Profile

Cover photo
Mayo Medical Laboratories
102 followers|18,917 views
AboutPostsPhotosYouTube

Stream

 
View this week’s Mayo Clinic PathWays case study by Melanie Bois, M.D., and Marie Christine Aubry, M.D., and make your diagnosis. ‪#‎pathology‬ http://mayocl.in/1F8e0ZK
View this week's case by Melanie Bois, M.D., and Marie Christine Aubry, M.D., and make your diagnosis.
1
Add a comment...
 
Jason Yuhas, Education Specialist at Mayo Clinic, has been elected President of the Association of Genetic Technologists​ Board of Directors. Yuhas will serve as president for four years, the first two years served as president-elect followed by a two-year term as president. http://mayocl.in/1FHSl10
Jason Yuhas, Education Specialist at Mayo Clinic, has been elected President of the Association of Genetic Technologists (AGT) Board of Directors. Yuhas will serve as president for four years, the first two years served as president-elect followed by a two-year term as president.
1
Add a comment...
 
Dabigatran etexilate (Pradaxa), an oral, direct thrombin inhibitor, was approved in October 2010 by the U.S. Food and Drug Administration for prevention of ‪#‎stroke‬ and thrombosis in patients with nonvalvular atrial fibrillation (AF). In a recent article in Clinical Chemistry, Mayo Clinic researchers, Hemamalini Ketha, Ph.D., and John Mills, Ph.D., discuss whether dabigatran is a risk to patient safety. http://mayocl.in/1PxjPeb
Dabigatran etexilate (Pradaxa), an oral, direct thrombin inhibitor, was approved in October 2010 by the U.S. Food and Drug Administration (FDA) for prevention of stroke and thrombosis in patients with nonvalvular atrial fibrillation (AF). In a recent article in Clinical Chemistry, Mayo Clinic researchers, Hemamalini Ketha, Ph.D., and John Mills, Ph.D., discuss whether dabigatran is a risk to patient safety.
1
Add a comment...
 
Mayo Clinic researchers recently developed an RT-PCR assay along with a break-apart FISH assay that can diagnose fibrolamellar carcinoma 100 percent of the time. The assays can detect the novel fusion at the transcriptional and genomic level, respectively. ‪#‎livercancer‬ http://mayocl.in/1II4Hqz
Mayo Clinic researchers recently developed an RT-PCR assay along with a break-apart FISH assay that can diagnose fibrolamellar carcinoma 100 percent of the time. The assays can detect the novel fusion at the transcriptional and genomic level, respectively.
1
Add a comment...
 
Ovarian ‪#‎cancer‬ is often sensitive to platinum-based chemotherapy, causing patients to develop resistance. Oncolytic measles virus MV expressing the sodium iodide symporter gene (MV-NIS) facilitates localization of viral gene expression and offers a tool for tumor radiovirotherapy. Mayo Clinic researchers conducted a study in the Cancer Research journal to determine the effect of MV-NIS in patients with treatment-resistant ‪#‎ovariancancer‬. http://mayocl.in/1RQ0DHs
Ovarian cancer is often sensitive to platinum-based chemotherapy, causing patients to develop resistance. Oncolytic measles virus (MV) expressing the sodium iodide symporter gene (MV-NIS) facilitates localization of viral gene expression and offers a tool for tumor radiovirotherapy. Mayo Clinic researchers conducted a study in the Cancer Research journal to determine the effect of MV-NIS in patients with treatment-resistant ovarian cancer.
1
Add a comment...
 
View this week’s Mayo Clinic PathWays case study by Joseph Maleszewski, M.D., and make your diagnosis. ‪#‎pathology‬ http://mayocl.in/1G2UoLI
View this week's case by Joseph Maleszewski, M.D., and make your diagnosis.
1
Add a comment...
Have them in circles
102 people
Raghid Sandouk's profile photo
Riz Chaudhry (Cen-Med)'s profile photo
Wang May's profile photo
Amy Beeman's profile photo
Isaac Newton's profile photo
Lab Tests Online's profile photo
Molly Griffin's profile photo
Kidney Disease Awareness , Battle , Cure's profile photo
BenchmarkPortal's profile photo
 
Mayo Clinic microbiologist Bobbi Pritt, M.D., talked about her unusual blog, “Creepy, Dreadful, Wonderful #Parasites: A Parasitologist’s View of the World.” with Mayo Clinic Radio. Listen to the podcast. #pathology http://mayocl.in/1HmFiNo
On the May 16 broadcast of Mayo Clinic Radio, microbiologist Bobbi Pritt, M.D., talked about her unusual blog, “Creepy, Dreadful, Wonderful Parasites: A Parasitologist’s View of the World.” The one-hour radio show highlights health and medical information from Mayo Clinic.
1
Add a comment...
 
MayoMedicalLaboratories.com has received a design and content refresh as part of a major initiative to improve the website and its user experience. The website includes new graphics, fonts, and updated content in nearly all sections. http://mayocl.in/1JE5Gao
MayoMedicalLaboratories.com has received a design and content refresh as part of a major initiative to improve the website and its user experience. The website includes new graphics, fonts, and updated content in nearly all sections.
1
Add a comment...
 
View this week’s Mayo Clinic PathWays case study by Tahir Mehmood, M.D. and Justin Kreuter, M.D., and make your diagnosis. ‪#‎pathology‬ http://mayocl.in/1PTIjcu
View this week's case by Tahir Mehmood, M.D. and Justin Kreuter, M.D., and make your diagnosis.
1
Add a comment...
 
Recurrent #kidneystones pose diagnostic and treatment challenges. In Part 2 of our Hot Topic series, we focus on both recurrent stones, as well as rare causes of kidney stones. http://mayocl.in/1EMnpqo
Recurrent kidney stones pose diagnostic and treatment challenges. In Part 2 of our Hot Topic series, we focus on both recurrent stones, as well as rare causes of kidney stones.
1
Add a comment...
 
The new Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered to assess a trough level quantitation for evaluation of patients with loss of response to infliximab. http://mayocl.in/1F7r8kZ
The new Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum, test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients. This test should be ordered to assess a trough level quantitation for evaluation of patients with loss of response to infliximab.
1
Add a comment...
 
Richter syndrome is defined as the transformation of chronic lymphocytic leukemia (CLL) to a more aggressive lymphoma. Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has shown significant efficacy in relapsed/refractory CLL. Mayo Clinic researchers conducted a study in Blood to determine the efficacy of ibrutinib in the treament of richter syndrome. http://mayocl.in/1ItWHcw
Richter syndrome is defined as the transformation of chronic lymphocytic leukemia (CLL) to a more aggressive lymphoma. Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has shown significant efficacy in relapsed/refractory CLL. Mayo Clinic researchers conducted a study in Blood to determine the efficacy of ibrutinib in the treament of richter syndrome.
1
Add a comment...
People
Have them in circles
102 people
Raghid Sandouk's profile photo
Riz Chaudhry (Cen-Med)'s profile photo
Wang May's profile photo
Amy Beeman's profile photo
Isaac Newton's profile photo
Lab Tests Online's profile photo
Molly Griffin's profile photo
Kidney Disease Awareness , Battle , Cure's profile photo
BenchmarkPortal's profile photo
Contact Information
Contact info
Email
Story
Tagline
Mayo Medical Laboratories is a global reference laboratory operating within Mayo Clinic’s Department of Laboratory Medicine and Pathology.
Introduction
Mission
Primary value: The needs of the patient come first.

To provide the best care to every patient every day through integrated clinical practice, education and research.
Description
The Department of Laboratory Medicine and Pathology's (DLMP) mission is to meet or exceed the expectations of physicians and others we serve worldwide with high-quality and cost-effective pathology and laboratory services that improve their ability to care for patients.

Through agreements with Mayo Clinic practices, Mayo Medical Laboratories clients can access DLMP's comprehensive laboratory services 24 hours a day, 7 days a week.

For more information, visit MayoMedicalLaboratories.com. For the latest news visit news.mayomedicallaboratories.com.